Results 171 to 180 of about 210,353 (388)

Alternative therapy interaction with warfarin: what doctors should know

Кардиоваскулярная терапия и профилактика, 2010
Warfarin effectiveness and safety is substantially affected by concurrent therapy. This paper reviews the main mechanisms of warfarin interactions with other agents, which underlie adverse effect development: platelet dysfunction, gastro-intestinal ...
T. B. Kozlova, T. V. Taratuta, M. B. Aksenova, T. V. Khlevchuk   +3 more
doaj  

Interaction between azapropazone and warfarin. [PDF]

, 1977
P R Powell-Jackson
openalex   +1 more source

Integrative proteomic analysis provides novel therapeutic insights for etiological subtypes of diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Type 2 diabetes (T2D) is a highly heterogeneous disease characterised by subtypes with variations in aetiology, disease progression, and risk of complications. However, potential drug targets for these subtypes have not been explored. This study aims to investigate potential drug targets by integrating proteomics.
Jiahe Wei, Hanzhang Wu, Ningjian Wang, Jiahao Zhu, Ranjit Mohan Anjana, Aleksandr V. Sokolov, Helgi B. Schiöth, Viswanathan Mohan, Xiao Tan   +8 more
wiley   +1 more source

Chondrodysplasia punctata and maternal warfarin treatment. [PDF]

, 1977
Alistair Abbott, J R Sibert, Judith B. Weaver   +2 more
openalex   +1 more source

Association between CMR‐derived hepatic T1‐time, tricuspid regurgitation and survival

European Journal of Clinical Investigation, EarlyView.
We investigated the association between tricuspid regurgitation (TR) severity and hepatic T1‐time in 1029 patients undergoing cardiac MRI and echocardiography. Hepatic T1‐time increased progressively with TR severity and remained independently associated after adjusting for NT‐proBNP and right ventricular function. Both TR and hepatic T1‐time predicted
Katharina Mascherbauer, Christina Kronberger, Manuel Gruber, Carolina Donà, Matthias Koschutnik, Varius Dannenberg, Michael Poledniczek, Laura Lunzer, Christian Nitsche, Franz Duca, Gregor Heitzinger, Kseniya Halavina, Dietrich Beitzke, Christian Loewe, Michael Trauner, Philipp Bartko, Julia Mascherbauer, Christian Hengstenberg, Andreas Kammerlander, Elisabeth Waldmann   +19 more
wiley   +1 more source

Correlation between Metabolic Parameters and Warfarin Dose in Patients with Heart Valve Replacement of Different Genotypes

Reviews in Cardiovascular Medicine
Background: Warfarin has become the first choice for anticoagulation in patients who need lifelong anticoagulation due to its clinical efficacy and low price.
Xiaowu Wang, Diancai Zhao, Jipeng Ma, Xia Wang, Jincheng Liu   +4 more
doaj   +1 more source

Reduction of salivary tissue factor (thromboplastin) activity by warfarin therapy [PDF]

, 1979
Zacharski Lr, Robert Rosenstein
openalex   +1 more source

Warfarin and extraction [PDF]

British Dental Journal, 2003
openaire   +2 more sources

Patient Characteristics, Healthcare Contacts and Drug Use in Polycythaemia Vera in Denmark

European Journal of Haematology, EarlyView.
ABSTRACT Objective Patients with polycythaemia vera (PV) may experience symptoms and cardiovascular complications before receiving a diagnosis. Understanding the associated patterns of healthcare and drug utilisation may help detect patients who need diagnostic workup.
Karoline Mathilde Lundgaard, Dustin Andersen Patel, Mette Brabrand, Christen Lykkegaard Andersen, Anton Pottegård   +4 more
wiley   +1 more source

Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more

Pharmacy Practice, 2012
In Estonia, warfarin is widely prescribed by general practitioners to prevent and treat thromboembolic diseases. To date, there has been no systematic analysis of the potential risk of warfarin interactions with other drugs in the outpatient population ...
Gavronski M, Hartikainen S, Zharkovsky A, Sautenkova N   +3 more
doaj